Monopar Therapeutics
MNPR
#7582
Rank
NZ$0.88 B
Marketcap
NZ$130.23
Share price
-0.94%
Change (1 day)
-3.20%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): NZ-$3.29

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$3.45. In 2025 the company made an earnings per share (EPS) of NZ-$3.35 an increase over its 2024 EPS that were of NZ-$7.43.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$3.29-1.55%
2025NZ-$3.35-54.99%
2024NZ-$7.4335.2%
2023NZ-$5.50-26.75%
2022NZ-$7.5113.7%
2021NZ-$6.6025.86%
2020NZ-$5.2528.89%
2019NZ-$4.0745.28%
2018NZ-$2.80-80.5%
2017NZ-$14.371296.33%
2016NZ-$1.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.44-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA